logo
Spacetech startup GalaxEye announces plans to build second satellite with 0.5m resolution

Spacetech startup GalaxEye announces plans to build second satellite with 0.5m resolution

Hans India20-06-2025
Bengaluru, 20th June, 2025 — GalaxEye, a Bengaluru-based space-tech startup pioneering Syncfusion SAR-Optical imaging satellite technology, has announced the development of its second satellite amid growing global demand for sharper and faster geospatial insights. Engineered to deliver near 0.5 metre resolution, the satellite will ensure elevation in detail and quality of insights for the defence use cases among other critical sectors.
The announcement follows closely on the heels of GalaxEye's upcoming first satellite, Mission Drishti, which is scheduled for launch later this year. Drishti offers a resolution of 1.25 metres and serves as a key milestone in demonstrating the company's proprietary technology stack, including a proven sensor system and Data Processing pipeline tested over 500 drone flights and spaceflight missions such as the POEM payload.
GalaxEye's second satellite will not only deliver improved spatial resolution but also reduce revisit time to under three days, significantly enhancing the responsiveness and utility of its constellation. Notably, the world's first SyncFusion SAR-Optical satellite, originally designed in India, will now also be fully built in-house—highlighting GalaxEye's growing manufacturing and systems integration capabilities. To support this expansion, the company also plans to scale its facilities in the near future.
'Building on the experience from our first satellite—set to launch later this year—and the evolving needs of our defence customers, we're thrilled to take the next big step in scaling our constellation and deepening our mission impact,' said Suyash Singh, Founder & CEO of GalaxEye. 'What excites us most is that this second satellite will be entirely built in-house. Our sensor stack has already been tested on over 500 aerial test flights, backed by a proprietary signal processing toolchain, the success of the POEM payload, the Drishti (1.25m) launch, and purpose-built software to extract actionable insights. As we move forward, we're committed to greater vertical integration—working closely with resilient partners across the satellite supply chain. The world today demands faster, sharper, and more persistent eyes in the sky. With enhanced resolution and performance, our second satellite marks a significant leap in unlocking richer, more detailed analytical intelligence.'
GalaxEye extends its gratitude towards ISRO, IN-SPACe and NAL for their guidance and support. Their commitment to nurturing India's space-tech ecosystem has been vital in our journey to push boundaries in Earth observation innovation. At a time when geopolitical conflicts and cross-border threats are escalating, nations are actively seeking sharper, more reliable satellite data to safeguard national interests. The second satellite, designed with mission-critical applications in mind, offers real-time, all-weather capabilities and will also serve adjacent sectors like disaster response, urban security, maritime awareness and risk intelligence.
'As early backers of GalaxEye, it's incredibly rewarding to see them announce their second satellite. The dual-use potential of their technology — spanning defence, national security, and commercial sectors — is truly exciting. GalaxEye's bold vision to bring reliability and Service Level Agreements to satellite imagery – all time all weather imagery – is a game-changer. We've believed in their mission from the start, and with the technology now de-risked, it's time to scale.' said Vishesh Rajaram, Managing Partner at Speciale Invest.
With the launch targeted for late 2026 or early 2027, the company is currently undergoing mission concept and preliminary design reviews, and is strategically positioning to expand into high-priority international defence markets including the United States, West Asia and Europe.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Chennai Metrowater pilots robotic cleaning in sewage pumping stations to boost efficiency and workers' safety
Chennai Metrowater pilots robotic cleaning in sewage pumping stations to boost efficiency and workers' safety

The Hindu

time3 hours ago

  • The Hindu

Chennai Metrowater pilots robotic cleaning in sewage pumping stations to boost efficiency and workers' safety

After deploying robots to clean sewer lines in some city zones, Chennai Metrowater is now piloting the use of robotic technology in sewage pumping stations in Thiruvanmiyur. The initiative aims to enhance operational safety and efficiency by minimising manual intervention. The water agency has already added Bandicoot Mobility, a robot that cleans maintenance holes of the sewer network, to remove clogged waste in sewer lines in zone 6 ( 9 (Teynampet) and 13 (Adyar). With robotic devices, which were developed by Genrobotics, a Kerala-based startup, helping to reduce clogging of lines for a year now, the water agency is exploring other innovative technologies to improve maintenance of sewer infrastructure. Officials of the Metrowater said an advanced robot with remote control unit and cameras, Wilboar, is being used to clean the sewage wells in Thiruvanmiyur sewage pumping station on a pilot basis. The robotic unit developed by Genrobotics is lowered into the wells that have a depth of up to 10 metre to remove the silt. With high-pressure water jets and grinders, the device grinds accumulated sludge into finer particles and clears them. This would eliminate the challenges in the use of conventional processes, improve efficiency of cleaning sewer wells and reduce complaints of sewage overflow in the pipelines. The Thiruvanmiyur sewage pumping station has a capacity to handle 15 million litres of sewage a day. Such robotic devices are already in use at Nellore, Andhra Pradesh and Thiruvananthapuram, Kerala, said officials. There are 375 sewage pumping stations in the city. Such robotic devices would be deployed in sewer well cleaning operations in other pumping stations following the success of the trial implementation. Rao, president, Chennai Metropolitan Water Supply and Sewerage Board Labourers Union, said it was a welcome initiative to ensure workers' safety and reduce manual intervention. Such efforts must be expanded to densely populated urban spaces and monitored for regular maintenance. Workers hired for sewer network maintenance should be redeployed to other roles. Nearly 2,850 labourers have been hired for sewer and water network maintenance in Chennai.

Logistics played key role in Operation Sindoor success, says Rajnath Singh
Logistics played key role in Operation Sindoor success, says Rajnath Singh

Economic Times

time3 hours ago

  • Economic Times

Logistics played key role in Operation Sindoor success, says Rajnath Singh

Synopsis Defence Minister Rajnath Singh lauded Indian agencies for their seamless logistics management during Operation Sindoor, emphasizing its crucial role in the operation's success. He highlighted that modern warfare relies not only on weaponry but also on the timely delivery of resources. Seamless logistics management by Indian agencies-from mobilisation of the armed forces to delivering equipment at the right time and place-was a deciding factor in the success of Operation Sindoor, defence minister Rajnath Singh said on Sunday. ADVERTISEMENT In a virtual address at the convocation ceremony of Vadodara-based Gati Shakti Vishwavidyalaya (GSV), the minister said in the current era, wars are not just won by guns and bullets but by time-bound delivery of material, highlighting Op Sindoor as an example of excellent logistics management. "Whether it's soldiers fighting on the border or personnel engaged in disaster management, without coordination or proper management of resources, even the strongest of intentions weaken. Logistics is the power that transforms chaos into control. Power is measured not only by weapons, but also by timely resource management. Be it war, disaster or global pandemic, the nation which keeps its logistics chain strong is the most stable, secure and capable," he said. (You can now subscribe to our Economic Times WhatsApp channel) (Catch all the Business News, Breaking News, Budget 2025 Events and Latest News Updates on The Economic Times.) Subscribe to The Economic Times Prime and read the ET ePaper online. NEXT STORY

Cheaper cancer care therapy earns big bucks for pharma company
Cheaper cancer care therapy earns big bucks for pharma company

Economic Times

time3 hours ago

  • Economic Times

Cheaper cancer care therapy earns big bucks for pharma company

India's cell and gene therapy pioneer ImmunoAct has turned profitable in its first full year of operations, a rare feat in the country's emerging startup landscape where research-based pharma enterprises encounter serious scale and cash flow challenges. ImmunoACT, in which Hyderabad-based drugmaker Laurus Labs has roughly 34% equity stake, saw revenues of ₹62 crore with a profit before tax of ₹12 crore in FY25, according to sources. The year before, ImmunoAct had revenues of ₹11 crore. Founded by immunologist Rahul Purwar in 2013, ImmunoACT was spun off from the department of bioengineering department of IIT Bombay in 2018. ImmunoACT's NexCAR19 is the first indigenously developed breakthrough cancer CAR-T (chimeric antigen receptor T-cell) therapy approved by India's central drug regulatory agency in October 2023. NexCAR19 was formally launched in India in April 2024 at a price ~90% cheaper than its US and European counterparts like Novartis and Gilead, making it far more affordable for India and low-and-middle income countries, on its potential approval. So far, the therapy has been infused in over 350 patients across 70 hospitals in India. In CAR-T treatment, the patient's immune cells are extracted and through a maze of re-engineering processes infused back to recognize and kill cancer cells, giving a longer remission to patients as compared to the conventional options like immunotherapy or bone marrow transplants. The therapy is used when all other options are CAR-T dose (one-and-done infusion) costs around ₹30 lakh, which was initially priced at ₹42 lakh, and is expected to see a further decline as demand picks ImmunoACT has recently appointed former managing director of Roche India V Simpson Immanuel as its strategic Purwar added, "We needed someone who understands not just the commercial landscape, but also the nuances of innovation, patient access, and global expansion." Earlier this year, Immuneel Therapeutics, backed by leading names like Kiran Mazumdar-Shaw and globally renowned oncologist Siddhartha Mukherjee secured approval for Qartemi, its cell therapy for adult B-cell non-Hodgkin Lymphoma, in India. Companies like Cipla, Dr Reddy's Labs and Bharat Biotech are investing heavily in new CAR-Ts. Globally, CAR-Ts are at the frontiers of a range of cancer treatments, attracting billions of dollars in investments from large drugmakers. The market for such therapies is expected to touch $134 billion by 2034 from around $10 billion at present.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store